The role of 'extra' DNA in cancer evolution and therapy resistance
Glioblastoma (GBM) is the most common and aggressive form of brain cancer. Response to standard-of-care treatment is poor, with a two-year survival rate of only 15 percent. Research is beginning to provide a better understanding ...
2 hours ago
27
0
27
0
